Skip to main content

Advertisement

Log in

Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (OSA)

  • Sleep Apnea (B. Rotenberg, Section Editor)
  • Published:
Current Otorhinolaryngology Reports Aims and scope Submit manuscript

Abstract

The prevalence of obstructive sleep apnea (OSA), its complex pathophysiology, and the suboptimal adherence rates with positive pressure therapy, necessitate alternative treatment strategies in many OSA patients. Hypoglossal nerve stimulation (HNS) represents a novel and unique therapeutic approach that combines a surgical implant procedure with a titratable medical device to provide multilevel upper airway improvement via neuromodulation of the hypoglossal nerve. A recent multicenter prospective trial reported significant reduction in polysomnographic measures of disease severity and significant improvement in patient-reported quality of life measures that were maintained at 3-year follow-up, with overall low morbidity and good patient acceptance and adherence. HNS therapy has established itself as a key component of the OSA treatment armamentarium, although further work is needed to advance the technology, determine the most appropriate patient phenotypes, refine the implant procedure, and optimize stimulation parameters and titration protocols.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Kushida CA, Nichols DA, Holmes TH, et al. Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: the apnea positive pressure long-term efficacy study (APPLES). Sleep. 2012;36:1593–602.

    Google Scholar 

  2. Rosen CL, Auckley D, Benca R, et al. A multisite randomized trial of portable sleep studies and positive airway pressure autotitration vs laboratory based polysomnography for the diagnosis and treatment of obstructive sleep apnea: the Home-PAP study. Sleep. 2012;35:757–67.

    Article  PubMed Central  PubMed  Google Scholar 

  3. White DP. Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med. 2005;172(11):1363–70. doi:10.1164/rccm.200412-1631SO.

    Article  PubMed  Google Scholar 

  4. Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP. Pathophysiology of sleep apnea. Physiol Rev. 2010;90(1):47–112. doi:10.1152/physrev.00043.2008.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Weaver EM, et al. Survival of veterans with sleep apnea: continuous positive airway pressure versus surgery. Otolaryngol Head Neck Surg. 2004;130:659–65.

    Article  PubMed  Google Scholar 

  6. Caples SM, Rowley JA, Prinsell JR, et al. Surgical modifications of the upper airway for obstructive sleep apnea in adults: a systematic review and meta-analysis. Sleep. 2010;33:1396–407.

    PubMed Central  PubMed  Google Scholar 

  7. Pirkbauer K, Russmueller G, Stiebellehner L, et al. Maxillomandibular advancement for treatment of obstructive sleep apnea syndrome: a systematic review. J Oral Maxillofac Surg. 2011;69:e165–76.

    Article  Google Scholar 

  8. Saboisky JP, Butler JE, McKenzie KD, et al. Neural drive to human genioglossus in obstructive sleep apnoea. J Physiol. 2007;585:135–46.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Ramchandren S, Gruis KL, Chervin RD, et al. Hypoglossal nerve conduction findings in obstructive sleep apnea. Muscle Nerve. 2010;42(2):257–61. doi:10.1002/mus.21690.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Ragab SM. Hypoglossal nerve conduction studies in patients with obstructive sleep apnea. Egypt J Otolaryngol. 2013;29:176–81.

    Google Scholar 

  11. Miki H, Hida W, Shindoh C, et al. Effects of electrical stimulation of the genioglossus on upper airway resistance in anesthetized dogs. Am Rev Respir Dis. 1989;140:1279–84.

    Article  CAS  PubMed  Google Scholar 

  12. Yoo PB, Durand DM. Effects of selective hypoglossal nerve stimulation on canine upper airway mechanics. J Appl Physiol. 2005;99:937–43.

    Article  PubMed  Google Scholar 

  13. Bishara H, Odeh M, Schnall RP, Gavriely N, Oliven A. Electrically-activated dilator muscles reduce pharyngeal resistance in anaesthetized dogs with upper airway obstruction. Eur Respir J. 1995;8:1537–42.

    CAS  PubMed  Google Scholar 

  14. Schwartz AR, Thut DC, Russ B, et al. Effect of electrical stimulation of the hypoglossal nerve on airflow mechanics in the isolated upper airway. Am Rev Respir Dis. 1993;147:1144–50.

    Article  CAS  PubMed  Google Scholar 

  15. Oliven A, Odeh M, Schnall RP. Improved upper airway patency elicited by electrical stimulation of the hypoglossus nerves. Respiration. 1996;63:213–6.

    Article  CAS  PubMed  Google Scholar 

  16. Eisele DW, Schwartz AR, Hari A, Thut DC, Smith PL. The effects of selective nerve stimulation on upper airway airflow mechanics. Arch Otolaryngol Head Neck Surg. 1995;121:1361–4.

    Article  CAS  PubMed  Google Scholar 

  17. Oliven A, Odeh M, Geitini L, et al. Effect of coactivation of tongue protrusor and retractor muscles on pharyngeal lumen and airflow in sleep apnea patients. J Appl Physiol. 2007;103:1662–8.

    Article  PubMed  Google Scholar 

  18. Schwartz AR, Bennett ML, Smith PL, et al. Therapeutic electrical stimulation of the hypoglossal nerve in obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 2001;127:1216–23.

    Article  CAS  PubMed  Google Scholar 

  19. Eastwood PR, Barnes M, Walsh JH, et al. Treating obstructive sleep apnea with hypoglossal nerve stimulation. Sleep. 2011;34:1479–86.

    PubMed Central  PubMed  Google Scholar 

  20. Van de Heyning PH, Badr MS, Baskin JZ, et al. Implanted upper airway stimulation device for obstructive sleep apnea. Laryngoscope. 2012;122:1626–33.

    Article  PubMed  Google Scholar 

  21. Vanderveken OM, Maurer JT, Hohenhorst W, et al. Evaluation of drug-induced sleep endoscopy as a patient selection tool for implanted upper airway stimulation for obstructive sleep apnea. J Clin Sleep Med. 2013;9:433–8.

    PubMed Central  PubMed  Google Scholar 

  22. •• Strollo PJ Jr, Soose RJ, Maurer JT, et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med. 2014;370:139–49. This was a multicenter, prospective, cohort study that showed reductions in AHI, ODI as well as improvement in quality of life measures with implantation of an upper airway stimulation device in 126 participants with obstructive sleep apnea. This also included a randomized arm that separated groups into therapy maintenance and withdrawal group and found that those in the withdrawal group had higher AHI after therapy was stopped. Also called the STAR trial.

  23. Woodson BT, Gillespie MB, Soose RJ, et al. Randomized controlled withdrawal study of upper airway stimulation on OSA: short-term and long-term effect. Otolaryngol Head Neck Surg. 2014;151:880–7.

    Article  PubMed  Google Scholar 

  24. Strollo PJ Jr, Gillespie MB, Soose RJ, et al. Upper airway stimulation for obstructive sleep apnea: durability of the treatment effect at 18 months. Sleep. 2015;38:1593–8.

    Article  PubMed  Google Scholar 

  25. • Soose RJ, Woodson BT, Gillespie MB, et al. Upper airway stimulation for obstructive sleep apnea: self-reported outcomes at 24 months. J Clin Sleep Med. 2016;12:43–8. This was a summary of 24-month outcome measures of the STAR trial. This was a multicenter, prospective cohort study of 126 patients who had implantation of an upper airway stimulation device. Quality of life measures such as scores about daytime sleepiness and snoring were measured, and all showed continued significant improvement.

  26. •• Woodson BT, Soose RJ, Gillespie MB, et al. Three-year outcomes of cranial nerve stimulation for obstructive sleep apnea: the STAR trial. Otolaryngol Head and Neck Surg. 2016;154:181–8. This paper was a summary of 3-year results of the STAR trial. 116 out of the original 126 participants had 36-month follow-up, and 91 of those patients underwent a 36-month PSG. Objective and subjective measures of sleep apnea continued to improve. Of note, 81% of participants reported using their device at 36-months. Very rare device side effects were reported, with 1 elective device explantation.

  27. • Schwartz AR, Barnes M, Hillman D, et al. Acute upper airway responses to hypoglossal nerve stimulation during sleep in obstructive sleep apnea. Am J Respir Crit Care Med 2012;185:420–6. This was a study examining whether hypoglossal nerve stimulation in 30 patients would lead to reduced pharyngeal airway collapsibility. This study found that hypoglossal nerve stimulation led to increases in pharyngeal airflow and relieved obstruction without arousing patients from sleep.

  28. Goding GS Jr, Tesfayesus W, Kezirian EJ. Hypoglossal nerve stimulation and airway changes under fluoroscopy. Otolaryngol Head Neck Surg. 2012;146:1017–22.

    Article  PubMed  Google Scholar 

  29. • Safiruddin F, Vanderveken OM, de Vries N, et al. Effect of upper-airway stimulation for obstructive sleep apnoea on airway dimensions. Eur Respir J. 2015;45(1):129–38. This study examined how upper airway stimulation effected retropalatal and retrolingual dimensions both during wakefulness and drug induced sleep. Cross sectional area, anterior-posterior and lateral dimensions were measured. This study showed that UAS works in a multidimensional nature and can simultaneously affect different portions of the airway.

  30. • Pietzsch JB, Liu S, Garner AM, et al. Long-term cost-effectiveness of upper airway stimulation for the treatment of obstructive sleep apnea: a model-based projection based on the STAR trial. Sleep. 2015;38:735–44. This study used a Markov model to conduct a cost-effectiveness study of UAS based on the result of the STAR trail. It found that UAS reduced relative risk of cardiovascular and MVC related morbidity and mortality. This resulted in a lifetime incremental cost-effectiveness ratio of $39,471 per each quality adjusted life year. The conclusion was that UAS is a cost-effective OSA therapy in the US payer healthcare market.

  31. Steffen A, Frenzel H, Wollenberg B, Konig IR. Patient selection for upper airway stimulation: is concentric collapse in sleep endoscopy predictable? Sleep Breath. 2015. doi:10.1007/s11325-015-1277-9.

    Google Scholar 

  32. Dedhia RC, Weaver EM. Association between drug-induced sleep endoscopy and measures of sleep apnea burden. Otolaryngol Head Neck Surg. 2015. doi:10.1177/0194599815595808.

    Google Scholar 

  33. Certal VF, Pratas R, Guimaraes L, et al. Awake examination versus DISE for surgical decision making in patients with OSA: a systematic review. Laryngoscope. 2015. doi:10.1002/lary.25722.

    Google Scholar 

  34. Bassiri GB, Tadisina KK, Rampazzo A, et al. Microsurgical anatomy of the terminal hypoglossal nerve relevant for neurostimulation in obstructive sleep apnea. Neuromodulation. 2015;18:721–8.

    Article  Google Scholar 

  35. Heiser C, Maurer JT, Steffen A. Functional outcome of tongue motions with selective hypoglossal nerve stimulation in patients with obstructive sleep apnea. Sleep Breath. 2015. doi:10.1007/s11325-015-1237-4.

    Google Scholar 

  36. Lee JJ, Sahu N, Rogers R, Soose RJ. Severe obstructive sleep apnea treated with combination hypoglossal nerve stimulation and oral appliance therapy. J Dental Sleep Med. 2015;2(4):185–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ryan J. Soose.

Additional information

This article is part of the Topical Collection on Sleep Apnea.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Govil, N., Soose, R.J. Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (OSA). Curr Otorhinolaryngol Rep 4, 6–12 (2016). https://doi.org/10.1007/s40136-016-0107-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40136-016-0107-3

Keywords

Navigation